secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001651308-25-000063
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeiGene shareholders approve redomestication from Cayman Islands to Switzerland at EGM
--------------------------------------------------------------------------------

- Special resolution to deregister in Cayman and continue to Switzerland passed with ~1.035B votes for, ~31K against.
- Related amendment and restatement of articles (Proposed Swiss Articles) approved with similar overwhelming support.
- Ernst & Young AG elected as Swiss statutory auditor until first AGM post-continuation; ~1.029B votes for.
- Continuation remains subject to conditions and is expected to close later this year.
- Quorum of ~74.6% of outstanding shares was present at the Extraordinary General Meeting on April 28, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000063/0001651308-25-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000063/bgne-20250428.htm
  HTML page:      https://secwatch.observer/filing/0001651308-25-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer